Hardy Diagnostics increases manufacturing to meet demand for COVID-19 related products

April 30, 2020

As demand surges, Hardy Diagnostics has exponentially increased manufacturing production in order to supply customers with critical laboratory products during the COVID-19 pandemic.

Caption: Hardy Diagnostics Viral Transport Medium is recommended for the collection and transport of clinical specimens for the recovery of viral agents including, but not limited to, Herpes Simplex Type I, Herpes Simplex Type II, Cytomegalovirus (CMV), Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Echovirus, Adenovirus, etc. To download image, click here.

Hardy Diagnostics, a 100% employee owned, FDA-licensed manufacturer headquartered in Santa Maria, CA, has been exponentially increasing production volume of products needed for testing during the COVID-19 global pandemic. Specifically, Hardy has increased production of Viral Transport Medium (VTM, Cat. No. R99), a product recommended by the CDC for collection and transportation of specimens from patients suspected of a COVID-19 infection. Hardy has increased production volumes from a few hundred tubes of VTM per week to now nearly 500,000 tubes per week. “The demand has placed incredible burden on our company, but one we are happy to support,” says Jay Hardy, Founder and President of Hardy Diagnostics. “It’s been nothing short of miraculous for us to be able to increase our production volumes so drastically. Every owner here at Hardy is proud to be supplying our American customers with these vital products.”

In addition to manufactured products like VTM, Hardy has opened up multiple supply chains for other difficult to obtain products. These include items such as surgical masks, hand sanitizers, and face shields. By working with international and local partners, Hardy Diagnostics has been receiving a steady supply of products and has been carefully allocating them to their customers. “With demand like this, we partner with our laboratory customers to ensure we understand their specific needs,” says Christopher Catani, Director of Sales and Marketing. “It’s incredibly challenging, because everyone is desperate. We’re doing our best to work closely with our customers to ensure we’re supporting them in every way possible.”

About Hardy Diagnostics:
Hardy Diagnostics is an FDA-licensed manufacturer of medical devices for microbiological testing with an ISO 13485 certified Quality Management System. The company manufactures over 2,700 products for the culture and identification of bacteria and fungi from its California and Ohio manufacturing facilities. Hardy Diagnostics is head-quartered in Santa Maria, California, and services over 10,000 laboratories across the nation. In 2015, the company became 100% employee-owned. The company was founded in 1980 by Jay Hardy, a Clinical Laboratory Scientist from Santa Barbara, California. Hardy Diagnostics maintains nine distribution centers nationwide and exports products to over 80 foreign distributors. Hardy Diagnostics’ mission is to produce and distribute the finest products for the detection of microorganisms and partner with its laboratory customers to diagnose and prevent disease. For more information on products and services and a complete profile on the company’s history, visit

Categories: Diagnostics & Hospital Laboratory, COVID-19
Browse more news

Recent releases